ArticleInternational journal of women's health2026
Choriocarcinoma Histologically Mimicking Epithelioid Trophoblastic Tumor - A Diagnostic Pitfall in Gestational Trophoblastic Neoplasia.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Histopathological diagnosis can be challenging because epithelioid trophoblastic tumor (ETT) may closely mimic choriocarcinoma, particularly due to overlapping cytologic and architectural features of intermediate trophoblasts. Therefore, immunohistochemical studies are essential for accurate classification of GTN subtypes. Case Illustration: A 27-year-old woman, para 4 abortion 1, with a history of two curettage procedures for partial hydatidiform mole, presented with persistent post-curettage vaginal bleeding for five months and was admitted to the emergency department with severe anemia. Serial β-hCG monitoring demonstrated a significant rise, raising suspicion for GTN. Ultrasonography revealed a vesicular pattern, while additional investigations showed no evidence of metastasis. Based on a FIGO score <7, the patient was classified as low-risk GTN. The patient declined chemotherapy and opted for total hysterectomy with bilateral salpingectomy. Intraoperative gross examination revealed an irregular, friable, and necrotic uterine mass consistent with GTN. Initial histopathological evaluation suggested epithelioid trophoblastic tumor; however, further immunohistochemical analysis demonstrated negative p63 expression, high Ki-67 index, and positive β-hCG staining, findings more consistent with choriocarcinoma. Discussion: This case highlights the importance of post-molar β-hCG surveillance as a cornerstone for early GTN diagnosis. The biological differences between ETT and choriocarcinoma have significant therapeutic implications, given the poorer chemotherapy response observed in ETT. Overlapping histopathological features emphasizes that diagnosis cannot rely solely on morphology but requires integration of clinical data, disease latency, β-hCG levels, and an appropriate immunohistochemical panel, particularly p63. Conclusion: Delayed post-molar β-hCG monitoring may lead to GTN progression and increased morbidity. Immunohistochemical examination plays a crucial role in differentiating ETT from choriocarcinoma to ensure accurate diagnosis and appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.